Autologous Fat Grafting
The use of autologous fat transfer was first reported in 1893 by Neuber. With the advent of liposuction and refinements in the technique, this procedure has evolved into a safe and predictable means of restoring facial volume. Its biocompatibility makes fat an ideal filler. Any area treatable with the commercial dermal fillers discussed in the previous section is potentially treatable with fat grafting. These areas include, but are not limited to, the periocular area, temples, forehead, brow, cheeks, midface, lips, nasolabial fold, jawline, submental crease, and chin. As with commercial dermal filler injection, fat grafting carries the risk of intravascular injection. Additionally, fat grafts can exhibit variable growth, resorption, or palpability if injected too superficially.
Excerpted from BCSC 2020-2021 series: Section 10 - Glaucoma. For more information and to purchase the entire series, please visit https://www.aao.org/bcsc.